FBXO5 and neoplasm: Although this remains to be formally tested, a possible tumour suppressive role may arise through its relationship with SKP2, where EMI1 prevents the uncontrolled degradation of SKP2 by APC/CCDH1, thereby allowing SCFSKP2 to regulate Cyclin E1 abundance preventing its aberrant accumulation.